Renal Dose Adjustment
Hepatic Dose Adjustment
See Supplemental Patient Information
Cautions: Use cautiously in
Supplemental Patient Information
Pregnancy Category:C
Breastfeeding: Lower occasional doses of are probably acceptable during breastfeeding. Higher doses or more long term use is associated with drowsiness and other effects in the infant and decreases the milk supply, particularly in combination with a sympathomimetic or before lactation is well established. This information is based upon Lactmed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 18 February 2011). According to manufacturers data higher risk exists in infants, newborns and premature in particular and use of carbinoxamine maleate is contraindicated in nursing mothers.
US Trade Name(s)
US Availability
carbinoxamine (generic)
Palgic
Arbinoxa
Karbinal ER
Canadian Trade Name(s)
Canadian Availability
UK Trade Name(s)
UK Availability
Australian Trade Name(s)
Australian Availability
Pricing data from www.DrugStore.com in U.S.A.
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.
Drug Name: Palgic 4 MG Oral Tablet
Ingredient(s): Carbinoxamine
Imprint: PAL;4
Color(s): White
Shape: Round
Size (mm): 7.00
Score: 2
Inactive Ingredient(s): anhydrous lactose / magnesium stearate / microcrystalline cellulose / sodium starch glycolate
Drug Label Author:
Pamlab, L.L.C.
DEA Schedule:
Non-Scheduled